Skip to content
Search

Latest Stories

Fluoxetine 40mg capsules back in pharmacy shelves to meet normal demand  

Following the expiry of SSP06 on October 2, there is now sufficient stock of Fluoxetine 40mg capsules to meet the normal demand.

Community pharmacies have been advised to dispense the drug prescribed after October 2. Fluoxetine 40mg capsules should be supplied to the patients in accordance with the prescription, as the SSP will no longer be valid for use.


Contractors should ensure that their SSP claims are appropriately submitted to NHS Business Services Authority for reimbursement.

Pharmacy teams are advised to submit SSP claims using the EPS token if their PMR systems do not support or capture all the SSP endorsement requirements for a valid claim.

If using a token to submit SSP claims, to avoid double-claiming, contractors are reminded to mark the item covered by the SSP as ‘Not Dispensed’/’ND’ on the EPS message.

Contractors have also been advised to check that the correct number of patient charges are collected and declared on the end of month FP34C submission form.

SSPs will be accepted for up to three calendar months after expiry or withdrawal of the SSP.

NHS BSA advises that contractor SSP claims should be clear and unambiguous and follow the protocol guidelines – NHS BSA processing staff must be able to determine what has been supplied.

Pharmacy contractors should keep a record of all SSP claims and reconcile when their Schedule of Payments are sent.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less